{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T10:48:44Z","timestamp":1786358924293,"version":"build-2736575974"},"reference-count":61,"publisher":"Informa UK Limited","issue":"1","license":[{"start":{"date-parts":[[2014,9,30]],"date-time":"2014-09-30T00:00:00Z","timestamp":1412035200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Global Health Action"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.3402\/gha.v7.24795","type":"journal-article","created":{"date-parts":[[2014,9,30]],"date-time":"2014-09-30T08:25:17Z","timestamp":1412065517000},"update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":26,"title":["Understanding reasons for treatment interruption amongst patients on antiretroviral therapy \u2013 A qualitative study at the Lighthouse Clinic, Lilongwe, Malawi"],"prefix":"10.1080","volume":"7","author":[{"given":"Julia","family":"Tabatabai","sequence":"first","affiliation":[{"name":"Institute of Public HealthUniversity of Heidelberg, Heidelberg, Germany"},{"name":"Department of Infectious DiseasesVirology, University of Heidelberg, Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ireen","family":"Namakhoma","sequence":"additional","affiliation":[{"name":"Reach Trust Lilongwe, Malawi"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannock","family":"Tweya","sequence":"additional","affiliation":[{"name":"The Lighthouse Trust Lilongwe, Malawi"},{"name":"The International Union against Tuberculosis and Lung Diseases Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sam","family":"Phiri","sequence":"additional","affiliation":[{"name":"The Lighthouse Trust Lilongwe, Malawi"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Schnitzler","sequence":"additional","affiliation":[{"name":"Department of Infectious DiseasesVirology, University of Heidelberg, Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Neuhann","sequence":"additional","affiliation":[{"name":"Institute of Public HealthUniversity of Heidelberg, Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2014,9,30]]},"reference":[{"key":"e_1_3_4_2_1","doi-asserted-by":"crossref","unstructured":"Schwartlander B Grubb I Perriens J. The 10-year struggle to provide antiretroviral treatment to people with HIV in the developing world. Lancet. 2006; 368: 541\u20136. [PubMed Abstract].","DOI":"10.1016\/S0140-6736(06)69164-2"},{"key":"e_1_3_4_3_1","unstructured":"UNAIDS. Global report: UNAIDS report on the global AIDS epidemic 2012. unaids.org. 2012. Available from: http:\/\/www.unaids.org\/en\/media\/unaids\/contentassets\/documents\/epidemiology\/2012\/gr2012\/20121120_UNAIDS_Global_Report_2012_with_annexes_en.pdf [cited 19 April 2013].."},{"key":"e_1_3_4_4_1","doi-asserted-by":"crossref","unstructured":"Egger M May M Ch\u00eane G Phillips AN Ledergerber B Dabis F etal. Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies. Lancet. 2002; 360: 119\u201329. [PubMed Abstract].","DOI":"10.1016\/S0140-6736(02)09411-4"},{"key":"e_1_3_4_5_1","doi-asserted-by":"crossref","unstructured":"Jahn A Floyd S Crampin AC Mwaungulu F Mvula H Munthali F etal. Population-level effect of HIV on adult mortality and early evidence of reversal after introduction of antiretroviral therapy in Malawi. Lancet. 2008; 371: 1603\u201311. [PubMed Abstract] [PubMed CentralFull Text].","DOI":"10.1016\/S0140-6736(08)60693-5"},{"key":"e_1_3_4_6_1","doi-asserted-by":"crossref","unstructured":"Floyd S Molesworth A Dube A Banda E Jahn A Mwafulirwa C etal. Population-level reduction in adult mortality after extension of free anti-retroviral therapy provision into rural areas in northern Malawi. PLoS One. 2010; 5: e13499. [PubMed Abstract] [PubMed CentralFull Text].","DOI":"10.1371\/journal.pone.0013499"},{"key":"e_1_3_4_7_1","doi-asserted-by":"crossref","unstructured":"Mahy M Stover J Stanecki K Stoneburner R Tassie J-M. Estimating the impact of antiretroviral therapy: regional and global estimates of life-years gained among adults. Sex Transm Infect. 2010; 86(Suppl 2):\nii67\u201371. [PubMed Abstract] [PubMed CentralFull Text].","DOI":"10.1136\/sti.2010.046060"},{"key":"e_1_3_4_8_1","doi-asserted-by":"crossref","unstructured":"Lawn SD Myer L Wood R. Efficacy of antiretroviral therapy in resource-poor settings: are outcomes comparable to those in the developed world?. Clin Infect Dis. 2005; 41: 1683\u20134. [PubMed Abstract].","DOI":"10.1086\/498030"},{"key":"e_1_3_4_9_1","doi-asserted-by":"crossref","unstructured":"Cohen MS Chen YQ McCauley M Gamble T Hosseinipour MC Kumarasamy N etal. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med. 2011; 365: 493\u2013505. [PubMed Abstract] [PubMed CentralFull Text].","DOI":"10.1056\/NEJMoa1105243"},{"key":"e_1_3_4_10_1","unstructured":"World Health Organization. Towards universal access: scaling up priority HIV\/AIDS interventions in the health sector. 2010; World Health Organization.\nAvailable from: http:\/\/whqlibdoc.who.int\/publications\/2010\/9789241500395_eng.pdf [cited 9 February 2013].."},{"key":"e_1_3_4_11_1","doi-asserted-by":"crossref","unstructured":"Fox MP Rosen S. Patient retention in antiretroviral therapy programs up to three years on treatment in sub-Saharan Africa 2007\u20132009: systematic review. Trop Med Int Health. 2010; 15(Suppl 1):\n1\u201315. [PubMed Abstract] [PubMed CentralFull Text].","DOI":"10.1111\/j.1365-3156.2010.02508.x"},{"key":"e_1_3_4_12_1","unstructured":"World Health Organization. Adherence to long-term therapies. World Health Organization. 2003. Available from: http:\/\/whqlibdoc.who.int\/publications\/2003\/9241545992.pdf [cited 9 February 2013]."},{"key":"e_1_3_4_13_1","doi-asserted-by":"crossref","unstructured":"Rosen S Fox MP Gill CJ. Patient retention in antiretroviral therapy programs in sub-Saharan Africa: a systematic review. PLoS Med. 2007; 4: e298. [PubMed Abstract] [PubMed CentralFull Text].","DOI":"10.1371\/journal.pmed.0040298"},{"key":"e_1_3_4_14_1","doi-asserted-by":"crossref","unstructured":"Kranzer K Govindasamy D Ford N Johnston V Lawn SD Kranzer K etal. Quantifying and addressing losses along the continuum of care for people living with HIV infection in sub-Saharan Africa: a systematic review. J Int AIDS Soc. 2012; 15: 17383. [PubMed Abstract] [PubMed CentralFull Text].","DOI":"10.7448\/IAS.15.2.17383"},{"key":"e_1_3_4_15_1","doi-asserted-by":"crossref","unstructured":"Gardner EM McLees MP Steiner JF Del Rio C Burman WJ. The spectrum of engagement in HIV care and its relevance to test-and-treat strategies for prevention of HIV infection. Clin Infect Dis. 2011; 52: 793\u2013800. [PubMed Abstract] [PubMed CentralFull Text].","DOI":"10.1093\/cid\/ciq243"},{"key":"e_1_3_4_16_1","doi-asserted-by":"crossref","unstructured":"Quinn TC Wawer MJ Sewankambo N Serwadda D Li C Wabwire-Mangen F etal. Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group. N Engl J Med. 2000; 342: 921\u20139. [PubMed Abstract].","DOI":"10.1056\/NEJM200003303421303"},{"key":"e_1_3_4_17_1","doi-asserted-by":"crossref","unstructured":"Donnell D Baeten JM Kiarie J Thomas KK Stevens W Cohen CR etal. Heterosexual HIV-1 transmission after initiation of antiretroviral therapy: a prospective cohort analysis. Lancet. 2010; 375: 2092\u20138. [PubMed Abstract] [PubMed CentralFull Text].","DOI":"10.1016\/S0140-6736(10)60705-2"},{"key":"e_1_3_4_18_1","doi-asserted-by":"crossref","unstructured":"Ivers LC Kendrick D Doucette K. Efficacy of antiretroviral therapy programs in resource-poor settings: a meta-analysis of the published literature. Clin Infect Dis. 2005; 41: 217\u201324. [PubMed Abstract].","DOI":"10.1086\/431199"},{"key":"e_1_3_4_19_1","doi-asserted-by":"crossref","unstructured":"Laurent C Ngom Gueye NF Ndour CT Gueye PM Diouf M Diakhat\u00e9 N etal. Long-term benefits of highly active antiretroviral therapy in Senegalese HIV-1-infected adults. J Acquir Immune Defic Syndr. 2005; 38: 14\u201317. [PubMed Abstract].","DOI":"10.1097\/00126334-200501010-00003"},{"key":"e_1_3_4_20_1","doi-asserted-by":"crossref","unstructured":"Gilks CF Crowley S Ekpini R Gove S Perriens J Souteyrand Y etal. The WHO public-health approach to antiretroviral treatment against HIV in resource-limited settings. Lancet. 2006; 368: 505\u201310. [PubMed Abstract].","DOI":"10.1016\/S0140-6736(06)69158-7"},{"key":"e_1_3_4_21_1","doi-asserted-by":"crossref","unstructured":"Oyugi JH Byakika-Tusiime J Ragland K Laeyendecker O Mugerwa R Kityo C etal. Treatment interruptions predict resistance in HIV-positive individuals purchasing fixed-dose combination antiretroviral therapy in Kampala Uganda. AIDS. 2007; 21: 965\u201371. [PubMed Abstract].","DOI":"10.1097\/QAD.0b013e32802e6bfa"},{"key":"e_1_3_4_22_1","doi-asserted-by":"crossref","unstructured":"Mills EJ Nachega JB Buchan I Orbinski J Attaran A Singh S etal. Adherence to antiretroviral therapy in sub-Saharan Africa and North America: a meta-analysis. JAMA. 2006; 296: 679\u201390. [PubMed Abstract].","DOI":"10.1001\/jama.296.6.679"},{"key":"e_1_3_4_23_1","doi-asserted-by":"crossref","unstructured":"Beach MC Keruly J Moore RD. Is the quality of the patient-provider relationship associated with better adherence and health outcomes for patients with HIV?. J Gen Intern Med. 2006; 21: 661\u20135. [PubMed Abstract] [PubMed CentralFull Text].","DOI":"10.1111\/j.1525-1497.2006.00399.x"},{"key":"e_1_3_4_24_1","doi-asserted-by":"crossref","unstructured":"Nachega JB Mills EJ Schechter M. Antiretroviral therapy adherence and retention in care in middle-income and low-income countries: current status of knowledge and research priorities. Curr Opin HIV AIDS. 2010; 5: 70. [PubMed Abstract].","DOI":"10.1097\/COH.0b013e328333ad61"},{"key":"e_1_3_4_25_1","doi-asserted-by":"crossref","unstructured":"Orrell C Bangsberg DR Badri M Wood R. Adherence is not a barrier to successful antiretroviral therapy in South Africa. AIDS. 2003; 17: 1369. [PubMed Abstract].","DOI":"10.1097\/00002030-200306130-00011"},{"key":"e_1_3_4_26_1","doi-asserted-by":"crossref","unstructured":"Nachega JB Uthman OA Anderson J Peltzer K Wampold S Cotton MF etal. Adherence to antiretroviral therapy during and after pregnancy in low-income middle-income and high-income countries: a systematic review and meta-analysis. AIDS. 2012; 26: 2039\u201352. [PubMed Abstract].","DOI":"10.1097\/QAD.0b013e328359590f"},{"key":"e_1_3_4_27_1","doi-asserted-by":"crossref","unstructured":"Bangsberg DR. Preventing HIV antiretroviral resistance through better monitoring of treatment adherence. J Infect Dis. 2008; 197(Suppl 3):\nS272\u20138. [PubMed Abstract].","DOI":"10.1086\/533415"},{"key":"e_1_3_4_28_1","doi-asserted-by":"crossref","unstructured":"Parienti J-J Massari V Descamps D Vabret A Bouvet E Larouz\u00e9 B etal. Predictors of virologic failure and resistance in HIV-infected patients treated with nevirapine- or efavirenz-based antiretroviral therapy. Clin Infect Dis. 2004; 38: 1311\u201316. [PubMed Abstract].","DOI":"10.1086\/383572"},{"key":"e_1_3_4_29_1","doi-asserted-by":"publisher","DOI":"10.3851\/IMP2536"},{"key":"e_1_3_4_30_1","doi-asserted-by":"crossref","unstructured":"Rasschaert F Koole O Zachariah R Lynen L Manzi M Van Damme W. Short and long term retention in antiretroviral care in health facilities in rural Malawi and Zimbabwe. BMC Health Serv Res. 2012; 12: 444. [PubMed Abstract] [PubMed CentralFull Text].","DOI":"10.1186\/1472-6963-12-444"},{"key":"e_1_3_4_31_1","doi-asserted-by":"crossref","unstructured":"Tweya H Gareta D Chagwera F Ben-Smith A Mwenyemasi J Chiputula F etal. Early active follow-up of patients on antiretroviral therapy (ART) who are lost to follow-up: the \u201cBack-to-Care\u201d project in Lilongwe Malawi. Trop Med Int Health. 2010; 15(Suppl 1):\n82\u20139. [PubMed Abstract].","DOI":"10.1111\/j.1365-3156.2010.02509.x"},{"key":"e_1_3_4_32_1","doi-asserted-by":"crossref","unstructured":"Kranzer K Ford N. Unstructured treatment interruption of antiretroviral therapy in clinical practice: a systematic review. Trop Med Int Health. 2011; 16: 1297\u2013313. [PubMed Abstract].","DOI":"10.1111\/j.1365-3156.2011.02828.x"},{"key":"e_1_3_4_33_1","doi-asserted-by":"crossref","unstructured":"Luebbert J Tweya H Phiri S Chaweza T Mwafilaso J Hosseinipour MC etal. Virological failure and drug resistance in patients on antiretroviral therapy after treatment interruption in Lilongwe Malawi. Clin Infect Dis. 2012; 55: 441\u20138. [PubMed Abstract].","DOI":"10.1093\/cid\/cis438"},{"key":"e_1_3_4_34_1","doi-asserted-by":"crossref","unstructured":"Gill CJ Hamer DH Simon JL Thea DM Sabin LL. No room for complacency about adherence to antiretroviral therapy in sub-Saharan Africa. AIDS. 2005; 19: 1243\u20139. [PubMed Abstract].","DOI":"10.1097\/01.aids.0000180094.04652.3b"},{"key":"e_1_3_4_35_1","doi-asserted-by":"crossref","unstructured":"Tuller DM Bangsberg DR Senkungu J Ware NC Emenyonu N Weiser SD. Transportation costs impede sustained adherence and access to HAART in a clinic population in southwestern Uganda: a qualitative study. AIDS Behav. 2010; 14: 778\u201384. [PubMed Abstract] [PubMed CentralFull Text].","DOI":"10.1007\/s10461-009-9533-2"},{"key":"e_1_3_4_36_1","doi-asserted-by":"crossref","unstructured":"Friedland GH. HIV medication adherence. The intersection of biomedical behavioral and social science research and clinical practice. J Acquir Immune Defic Syndr. 2006; 43(Suppl 1):\nS3\u20139. [PubMed Abstract].","DOI":"10.1097\/01.qai.0000248333.44449.ea"},{"key":"e_1_3_4_37_1","unstructured":"Ministry of Health Malawi. Treatment of AIDS. 2008; Lilongwe: Ministry of Health Malawi.\n3rd ed. hivunitmohmw.org."},{"key":"e_1_3_4_38_1","doi-asserted-by":"crossref","unstructured":"Harries AD Makombe SD Libamba E Schouten EJ. Why did the scale-up of HIV treatment work? A case example from Malawi. J Acquir Immune Defic Syndr. 2011; 57(Suppl 2):\nS64\u20137. [PubMed Abstract].","DOI":"10.1097\/QAI.0b013e31821f6bab"},{"key":"e_1_3_4_39_1","unstructured":"World Health Organization. Malawi \u2013 summary country profile for HIV\/AIDStreatmentscale-up. 2005. who.int. Available from: http:\/\/www.who.int\/hiv\/HIVCP_MWI.pdf [cited 6 May 2013].."},{"key":"e_1_3_4_40_1","unstructured":"Malawi Government. 2012 Global AIDS response progress report: Malawi Country report for 2010 and 2011. 2012. unaids.org. Available from: http:\/\/www.unaids.org\/en\/dataanalysis\/knowyourresponse\/countryprogressreports\/2012countries\/ce_MW_Narrative_Report[1].pdf [cited 2 May 2013].."},{"key":"e_1_3_4_41_1","doi-asserted-by":"crossref","unstructured":"Harries AD Zachariah R Jahn A Schouten EJ Kamoto K. Scaling up antiretroviral therapy in Malawi-implications for managing other chronic diseases in resource-limited countries. J Acquir Immune Defic Syndr. 2009; 52(Suppl 1):\nS14\u201316. [PubMed Abstract].","DOI":"10.1097\/QAI.0b013e3181bbc99e"},{"key":"e_1_3_4_42_1","unstructured":"Phiri S Weigel R Housseinipour M Boxshall M. The Lighthouse: a centre for comprehensive HIV\/AIDS treatment and care in Malawi. 2004; Geneva: WHO.\nCase study."},{"key":"e_1_3_4_43_1","doi-asserted-by":"crossref","unstructured":"Taylor-Smith K Tweya H Harries A Schoutene E Jahn A. Gender differences in retention and survival on antiretroviral therapy of HIV-1 infected adults in Malawi. Malawi Med J. 2010; 22: 49\u201356. [PubMed Abstract] [PubMed CentralFull Text].","DOI":"10.4314\/mmj.v22i2.58794"},{"key":"e_1_3_4_44_1","unstructured":"Ministry of Health Malawi. Malawi Antiretroviral Treatment Programme \u2013 Quarterly report Q4 2009. Malawi Ministry of Health. Ministry of Health Malawi. 2010. Available from: http:\/\/www.hivunitmohmw.org\/Main\/AntiretroviralTherapy [cited 17 February 2013].."},{"key":"e_1_3_4_45_1","unstructured":"Corbin J Strauss A. Basics of qualitative research. 2008; Thousand Oaks: Sage.\n3rd ed."},{"key":"e_1_3_4_46_1","doi-asserted-by":"crossref","unstructured":"Pope C Ziebland S Mays N. Qualitative research in health care. Analysing qualitative data. BMJ. 2000; 320: 114\u201316. [PubMed Abstract] [PubMed CentralFull Text].","DOI":"10.1136\/bmj.320.7227.114"},{"key":"e_1_3_4_47_1","doi-asserted-by":"crossref","unstructured":"Cook KE. Reliability assessments in qualitative health promotion research. Health Promot Int. 2012; 27: 90\u2013101. [PubMed Abstract].","DOI":"10.1093\/heapro\/dar027"},{"key":"e_1_3_4_48_1","doi-asserted-by":"crossref","unstructured":"Boyer S Clerc I Bonono C-R Marcellin F Bil\u00e9 P-C Ventelou B. Non-adherence to antiretroviral treatment and unplanned treatment interruption among people living with HIV\/AIDS in Cameroon: Individual and healthcare supply-related factors. Soc Sci Med. 2011; 72: 1383\u201392. [PubMed Abstract].","DOI":"10.1016\/j.socscimed.2011.02.030"},{"key":"e_1_3_4_49_1","doi-asserted-by":"crossref","unstructured":"Weigel R Estill J Egger M Harries AD Makombe S Tweya H etal. Mortality and loss to follow-up in the first year of ART: Malawi national ART programme. AIDS. 2012; 26: 365\u201373. [PubMed Abstract].","DOI":"10.1097\/QAD.0b013e32834ed814"},{"key":"e_1_3_4_50_1","doi-asserted-by":"crossref","unstructured":"Kranzer K Lewis JJ Ford N Zeinecker J Orrell C Lawn SD etal. Treatment interruption in a primary care antiretroviral therapy program in South Africa: cohort analysis of trends and risk factors. J Acquir Immune Defic Syndr. 2010; 55: e17\u201323. [PubMed Abstract] [PubMed CentralFull Text].","DOI":"10.1097\/QAI.0b013e3181f275fd"},{"key":"e_1_3_4_51_1","doi-asserted-by":"crossref","unstructured":"Do NT Phiri K Bussmann H Gaolathe T Marlink RG Wester CW. Psychosocial factors affecting medication adherence among HIV-1 infected adults receiving combination antiretroviral therapy (cART) in Botswana. AIDS Res Hum Retroviruses. 2010; 26: 685\u201391. [PubMed Abstract] [PubMed CentralFull Text].","DOI":"10.1089\/aid.2009.0222"},{"key":"e_1_3_4_52_1","doi-asserted-by":"crossref","unstructured":"Hardon AP Akurut D Comoro C Ekezie C Irunde HF Gerrits T etal. Hunger waiting time and transport costs: time to confront challenges to ART adherence in Africa. AIDS Care. 2007; 19: 658\u201365. [PubMed Abstract].","DOI":"10.1080\/09540120701244943"},{"key":"e_1_3_4_53_1","unstructured":"Hardon A Davey S Gerrits T Hodgkin C Irunde H. From access to adherence: the challenges of antiretroviral treatment. 2006; Geneva: WHO."},{"key":"e_1_3_4_54_1","doi-asserted-by":"crossref","unstructured":"Rachlis B Ahmad F van Lettow M Muula AS Semba M Cole DC. Using concept mapping to explore why patients become lost to follow up from an antiretroviral therapy program in the Zomba District of Malawi. BMC Health Serv Res. 2013; 13: 210. [PubMed Abstract] [PubMed CentralFull Text].","DOI":"10.1186\/1472-6963-13-210"},{"key":"e_1_3_4_55_1","doi-asserted-by":"crossref","unstructured":"Zachariah R Harries AD Manzi M Gomani P Teck R Phillips M etal. Acceptance of anti-retroviral therapy among patients infected with HIV and tuberculosis in rural Malawi is low and associated with cost of transport. PLoS One. 2006; 1: e121. [PubMed Abstract] [PubMed CentralFull Text].","DOI":"10.1371\/journal.pone.0000121"},{"key":"e_1_3_4_56_1","doi-asserted-by":"crossref","unstructured":"Yu JK-L Chen SC-C Wang K-Y Chang C-S Makombe SD Schouten EJ etal. True outcomes for patients on antiretroviral therapy who are \u201clost to follow-up\u201d in Malawi. Bull World Health Organ. 2007; 85: 550\u20134. [PubMed Abstract] [PubMed CentralFull Text].","DOI":"10.2471\/BLT.06.037739"},{"key":"e_1_3_4_57_1","doi-asserted-by":"crossref","unstructured":"Dlamini PS Wantland D Makoae LN Chirwa M Kohi TW Greeff M etal. HIV stigma and missed medications in HIV-positive people in five African countries. AIDS Patient Care STDS. 2009; 23: 377\u201387. [PubMed Abstract] [PubMed CentralFull Text].","DOI":"10.1089\/apc.2008.0164"},{"key":"e_1_3_4_58_1","doi-asserted-by":"crossref","unstructured":"Dowshen N Kuhns LM Gray C Lee S Garofalo R. Feasibility of interactive text message response (ITR) as a novel real-time measure of adherence to antiretroviral therapy for HIV+ youth. AIDS Behav. 2013; 17: 2237\u201343. [PubMed Abstract].","DOI":"10.1007\/s10461-013-0464-6"},{"key":"e_1_3_4_59_1","doi-asserted-by":"crossref","unstructured":"Kunutsor S Walley J Katabira E Muchuro S Balidawa H Namagala E etal. Using mobile phones to improve clinic attendance amongst an antiretroviral treatment cohort in rural Uganda: a cross-sectional and prospective study. AIDS Behav. 2010; 14: 1347\u201352. [PubMed Abstract].","DOI":"10.1007\/s10461-010-9780-2"},{"key":"e_1_3_4_60_1","doi-asserted-by":"crossref","unstructured":"Pop-Eleches C Thirumurthy H Habyarimana JP Zivin JG Goldstein MP de Walque D etal. Mobile phone technologies improve adherence to antiretroviral treatment in a resource-limited setting: a randomized controlled trial of text message reminders. AIDS. 2011; 25: 825\u201334. [PubMed Abstract] [PubMed CentralFull Text].","DOI":"10.1097\/QAD.0b013e32834380c1"},{"key":"e_1_3_4_61_1","unstructured":"Ministry of Health Malawi. Integrated HIV program report October \u2013 December 2012. 2012; Malawi Ministry of Health.\nAvailable from: http:\/\/www.hivunitmohmw.org\/uploads\/Main\/Quarterly_HIV_Programme_Report_2012_Q4.pdf [cited 1 May 2013].."},{"key":"e_1_3_4_62_1","unstructured":"Tradingeconomics. Malawi inflation rate. tradingeconomics.com. 2013. Available from: http:\/\/www.tradingeconomics.com\/malawi\/inflation-cpi [cited 19 August 2013].."}],"container-title":["Global Health Action"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.3402\/gha.v7.24795","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,24]],"date-time":"2024-01-24T11:41:01Z","timestamp":1706096461000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.3402\/gha.v7.24795"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9,30]]},"references-count":61,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["10.3402\/gha.v7.24795"],"URL":"https:\/\/doi.org\/10.3402\/gha.v7.24795","relation":{},"ISSN":["1654-9716","1654-9880"],"issn-type":[{"value":"1654-9716","type":"print"},{"value":"1654-9880","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,9,30]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=zgha20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=zgha20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2014-04-29","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2014-09-04","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2014-09-30","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"24795"}}